LENALIDOMIDE TREATMENT IN 5Q(-) SYNDROME: A SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Uskudar, H. Teke [1 ]
Andic, N. [1 ]
Gunduz, E. [1 ]
Ozpolat, S. [2 ]
Aras, B. Durak [2 ]
Akay, O. [1 ]
机构：
[1] Eskisehir Osmangazi Univ, Fac Med, Hematol, Eskisehir, Turkey
[2] Eskisehir Osmangazi Univ, Fac Med, Genet, Eskisehir, Turkey
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30198-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
197
引用
收藏
页码：S98 / S99
页数：2
相关论文
共 50 条
  • [1] Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q)
    Butrym, Aleksandra
    Lech-Maranda, Ewa
    Patkowska, Elzbieta
    Kumiega, Beata
    Bieniaszewska, Maria
    Mital, Andrzej
    Madry, Krzysztof
    Torosian, Tigran
    Wichary, Ryszard
    Rybka, Justyna
    Warzocha, Krzysztof
    Mazur, Grzegorz
    BMC CANCER, 2015, 15
  • [2] Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q)
    Aleksandra Butrym
    Ewa Lech-Maranda
    Elżbieta Patkowska
    Beata Kumiega
    Maria Bieniaszewska
    Andrzej Mital
    Krzysztof Madry
    Tigran Torosian
    Ryszard Wichary
    Justyna Rybka
    Krzysztof Warzocha
    Grzegorz Mazur
    BMC Cancer, 15
  • [3] Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion-The GFM experience
    Le Bras, Fabien
    Sebert, Marie
    Kelaidi, Charikleia
    Lamy, Thierry
    Dreyfus, Francois
    Delaunay, Jacques
    Banos, Anne
    Blanc, Michel
    Vey, Norbert
    Schmidt, Aline
    Visanica, Sorin
    Eclache, Virginie
    Turlure, Pascal
    Beyne-Rauzy, Odile
    Guerci, Agnes
    Delmer, Alain
    de Botton, Stephane
    Rea, Delphine
    Fenaux, Pierre
    Ades, Lionel
    LEUKEMIA RESEARCH, 2011, 35 (11) : 1444 - 1448
  • [4] MYELODYSPLASTIC SYNDROME WITH DEL(5Q) AND LENALIDOMIDE
    Gritsaev, S. V.
    Martinkevitch, I. S.
    Petrova, E. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2013, 58 (02): : 3 - 10
  • [5] Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
    List, Alan
    Dewald, Gordon
    Bennett, John
    Giagounidis, Aristotle
    Raza, Azra
    Feldman, Eric
    Powell, Bayard
    Greenberg, Peter
    Thomas, Deborah
    Stone, Richard
    Reeder, Craig
    Wride, Kenton
    Patin, John
    Schmidt, Michele
    Zeldis, Jerome
    Knight, Robert
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1456 - 1465
  • [6] Azacitidine Treatment of Lenalidomide-Resistant Myelodysplastic Syndrome with Deletion 5q
    Komrokji, Rami S.
    Al Ali, Najla H.
    Padron, Eric
    Lancet, Jeffrey E.
    List, Alan F.
    BLOOD, 2011, 118 (21) : 1195 - 1195
  • [7] Lenalidomide in 5q-syndrome: A single centre experience
    Sanpaolo, G.
    Falcone, A.
    La Sala, A.
    Bodenizza, C.
    Carella, A. M.
    de, Cillis G.
    Dell'Olio, M.
    Greco, M. M.
    Mantuano, F. S.
    Melillo, I
    Merla, E.
    Mangione, I
    Minervini, M. M.
    Perla, G.
    Nobile, M.
    Savino, L.
    Scalzulli, P. R.
    Valente, D.
    Cascavilla, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 210 - 210
  • [8] Survival of Patients with Del(5q) Syndrome in the Lenalidomide Era
    Reagan, John L.
    Ollila, Thomas
    Dubielecka, Patrycja M.
    Olszewski, Adam J.
    BLOOD, 2016, 128 (22)
  • [9] LENALIDOMIDE IN A COHORT OF VERY ELDERLY PATIENTS WITH MYELODYSPLASIA AND DEL(5Q): A SINGLE CENTRE EXPERIENCE
    Capodanno, I.
    Avanzini, P.
    Franchi, F.
    Merli, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 565 - 566
  • [10] Treatment of deletion 5q acute myeloid leukemia with lenalidomide
    J E Lancet
    A F List
    L C Moscinski
    Leukemia, 2007, 21 : 586 - 588
12345